Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes
Clinical trial NCT05979415 · TERMINATED
Trial details
- NCT number
- NCT05979415
- Sponsor
- Alexza Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-02-28
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.